10808 Federal Register / Vol. 75, No. 45 / Tuesday, March 9, 2010 / Notices 

The agenda is subject to change as 

priorities dictate. 

This meeting is open to the public, but 

without a public comment period. In the 

event an individual wishes to provide 

comments, written comments may be 

submitted. Any written comments received 

will be provided at the meeting and should 

be submitted to the contact person below in 

advance of the meeting. 

Contact Person for More Information: 

Theodore Katz, Executive Secretary, NIOSH, 

CDC, 1600 Clifton Road, Mailstop E–20, 

Atlanta, Georgia 30333, Telephone: (513) 

533–6800, Toll Free: 1(800) CDC–INFO, Email ocas@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–4890 Filed 3–8–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Nursing Research; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Nursing Research, Special Emphasis Panel, 

NINR Loan Repayment Program Review 

(L30/L40). 

Date: March 29, 2010. 

Time: 9 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Ste. 710, Bethesda, MD 20892. 

(Telephone Conference Call) 

Contact Person: Mario Rinaudo, MD, 

Scientific Review Administrator, Office of 

Review, National Institute of Nursing 

Research, National Institutes of Health, 6701 

Democracy Blvd (DEM 1), Suite 710, 

Bethesda, MD 20892, 301–594–5973, 

mrinaudo@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.361, Nursing Research, 

National Institutes of Health, HHS) 

Dated: March 1, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–4753 Filed 3–8–10; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Alcohol Abuse 

and Alcoholism; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Special 

Emphasis Panel; Review of Alcohol Resource 

Grant Applications. 

Date: April 6, 2010. 

Time: 2 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications 

Place: National Institutes of Health, 5635 

Fishers Lane, Bethesda, MD 20892. 

(Telephone Conference Call) 

Contact Person: Richard A Rippe, Ph.D., 

Scientific Review Officer, National Institute 

on Alcohol Abuse & Alcoholism, National 

Institutes of Health, 5635 Fishers Lane, Rm. 

2109, Rockville, MD 20852, 301–443–8599, 

rippera@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.271 Alcohol Research 

Career Development Awards for Scientists 

and Clinicians; 93.272, Alcohol National 

Research Service Awards for Research 

Training; 93.273, Alcohol Research Programs; 

93.891, Alcohol Research Center Grants; 

93.701, ARRA Related Biomedical Research 

and Research Support Awards, National 

Institutes of Health, HHS) 

Dated: March 1, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–4750 Filed 3–8–10; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket Nos. FDA–2005–C–0245, FDA– 

2005–C–0416, and FDA–2005–C–0504] 

(formerly Docket Nos. 2005C–0302, 2005C– 

0303, and 2005C–0304) 

CIBA Vision Corp.; Withdrawal of Color 

Additive Petitions 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing the 

withdrawal, without prejudice to a 

future filing, of three color additive 

petitions (CAP 5C0278, CAP 5C0279, 

and CAP 5C0280) proposing that the 

color additive regulations be amended 

to provide for the safe use of Color 

Index (C.I.) Pigment Violet 19, C.I. 

Pigment Yellow 154, and C.I. Pigment 

Red 122 as color additives in contact 

lenses. 

FOR FURTHER INFORMATION CONTACT: 

Celeste Johnston, Center for Food Safety 

and Applied Nutrition (HFS–265), Food 

and Drug Administration, 5100 Paint 

Branch Pkwy., College Park, MD 20740– 

3835, 301–436–1282. 

SUPPLEMENTARY INFORMATION: In a notice 

published in the Federal Register of 

August 17, 2005 (70 FR 48426), FDA 

announced that three color additive 

petitions had been filed by CIBA Vision 

Corp., 11460 Johns Creek Pkwy., 

Duluth, GA 30097–1556. The petitions 

proposed to amend the color additive 

regulations in Part 73 Listing of Color 

Additives Exempt from Certification (21 

CFR part 73) to provide for the safe use 

of C.I. Pigment Violet 19 (CAP 5C0278, 

Docket No. FDA–2005–C–0245), C.I. 

Pigment Yellow 154 (CAP 5C0279, 

Docket No. FDA–2005–C–0416), and C.I. 

Pigment Red 122 (CAP 5C0280, Docket 

No. FDA–2005–C–0504) as color 

additives in contact lenses. CIBA Vision 

Corp. has now withdrawn the petitions 

without prejudice to a future filing (21 

CFR 71.6(c)(2)). 


sroberts on DSKD5P82C1PROD with NOTICES